Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV

Delayed Quote. Delayed  - 07/31 01:13:04 pm
70.01 USD   -0.21%
07/28DJExpress Scripts Raises Guidance as Earnings Top Views
07/28DJExpress Scripts Raises Guidance as Earnings Top Views
07/28DJGilead Sales Soar on Hepatitis Drugs
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
69.34(c) 71.23(c) 70.77(c) 70.16(c) 70.01 Last
12 841 481 10 098 343 6 793 252 6 820 441 1 907 803 Volume
+1.85% +2.73% -0.65% -0.86% -0.21% Change
More quotes
Financials ($)
Sales 2015 23 073 M
EBIT 2015 9 449 M
Net income 2015 6 455 M
Debt 2015 14 474 M
Yield 2015 2,98%
Sales 2016 26 595 M
EBIT 2016 11 328 M
Net income 2016 8 209 M
Debt 2016 14 481 M
Yield 2016 3,27%
PER 2015 18,59
PER 2016 14,43
EV / Sales 2015 5,47x
EV / Sales 2016 4,75x
Capitalization 111 770 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
04:15a BRISTOL MYERS SQUIBB : Reported that European Medicines Agency Validates and Gra..
03:04a ABBVIE : Testosterone Lawsuit News: Androgel Lawsuit Conference Held
07/30 VITAE PHARMACEUTICALS : Appoints Dr. John M. Leonard to Board of Directors
07/30 BRISTOL MYERS SQUIBB : Reported that European Medicines Agency Validates and Gra..
07/30 ENANTA PHARMACEUTICALS : Gets U.S. Regulatory Approval of TECHNIVIE (ombitasvir,..
07/30 ABBVIE : Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpo..
07/29 ABBVIE : C2N and AbbVie Announce FDA Orphan Drug Designation of C2N-8E12 ABBV-8E..
07/29 ENANTA PHARMACEUTICALS : Secures U.S. Regulatory Approval of TECHNIVIE (ombitasv..
More news
Sector news : Biopharmaceuticals
01:23p TEVA PHARMACEUTICAL : Secures $33.75 Billion Financing Commitment
10:52a PFIZER : Dow Movers: CVX, PFE
10:52a NASDAQ 100 MOVERS : Wfm, amgn
More sector news : Biopharmaceuticals
4-Traders Strategies on ABBVIE INC 
02/13A likely recovery
More Strategies
News from SeekingAlpha
07/30 AbbVie Poised For Continued Success
07/30 GILEAD BEATS AND RAISES AGAIN : Why I've Stayed Overweight
07/29 GILEAD BEATS AND RAISES : Thinking Through The Future Of Its Business And Its St..
07/29 Gilead Sciences Beats And Guidance Raise Give It Room To Run Upward
07/29 Gilead Blows By 2Q Estimates; Investors Getting Drug Pipeline For Free


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions